3-(PIPERAZIN-1-YL)TETRAHYDROTHIOPHENE 1,1-DIOXIDE HCL, 95.0%, 2g

4-(hydroxyimino)-1,2,3,4-tetrahydropyrimidin-2-one, 95%, 25mg

2-Chloro-4-fluoro-3-methylbenzoic acid, 97.0%, 10g

Ethyl 2-amino-3-chloro-4-methylbenzoate, 98%, 500mg

1-Ethyl-3-methylimidazolium hexafluorophosphate, 98.0%, 1g

N-(2-Chloro-4-iodophenyl)acetamide, 97%, 5g

Diethyl 2-acetylsuccinate, 95.0%, 10g

Oxion Inverso OX.2053-PL with LWD Plan 10x/20x/40x objectives and XY cross table

(R)-GAMMA-VALEROLACTONE, 95%, 250mg

[(1S)-1-phenylethyl](propan-2-yl)amine, 95.0%, 2.5g

4-Methyl-1-cyclohexene500mL

3-(3-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 97%, 25g

Ethyl 1-Methyl-3-piperidinecarboxylate>95.0%(GC)(T)5g